Global Journal of Oncology Drug Development and Care

Welcome to the Global Journal of Oncology Drug Development and Care (GJODDC) – an open-access, peer-reviewed international journal committed to advancing the science, innovation, and delivery of drug development in the field of oncology. Our mission is to bridge the gap between laboratory research, clinical development, regulatory frameworks, and patient-centered cancer care through impactful and translational publications.

GJODDC serves as a vital platform for researchers, clinicians, pharmaceutical professionals, oncologists, and policymakers to explore novel anticancer agents, breakthrough therapies, precision medicine strategies, and evolving paradigms in oncology drug care.

Scope of the Journal:

GJODDC publishes original research, reviews, case reports, brief communications, and commentaries across a broad spectrum of topics, including but not limited to:

• Preclinical and clinical drug development in oncology
• Molecular targets and biomarkers in cancer therapy
• Immunotherapy and targeted drug therapies
• Pharmacokinetics, pharmacodynamics, and drug delivery systems
• Regulatory affairs and global clinical trial practices
• Patient safety, adherence, and supportive oncology care
• Oncology pharmacy practice and innovations

Why Publish with GJODDC?

• Rigorous double-blind peer review by field experts
• Wide global reach with open-access visibility
• Rapid publication timelines with continuous online hosting
• Ethical publishing aligned with COPE and ICMJE guidelines
• Platform for multidisciplinary collaboration in oncology and pharmacy

Call for Papers

We welcome submissions from researchers and professionals involved in all stages of cancer drug discovery, development, and clinical practice. Share your valuable insights and contribute to the future of oncology therapeutics.

Stay Connected

Explore, publish, and innovate with GJODDC.